Low-dose rotavirus vaccine variant Rotavac 5D is introduced

▴ Bharat Biotech
Bharat Biotech, an Indian vaccine manufacturer, came out with a low dose-volume variant of its anti-diarrhoea rotavirus vaccine

Bharat Biotech, an Indian vaccine manufacturer, came out with a low dose-volume variant of its anti-diarrhoea rotavirus vaccine--Rotavac 5D recently that's expected to hamper the availability chain and delivery costs per dose. This variant is claimed to be available is little five-dose vials of 0.5 ml doses each.

The latest variant also can be stored in 2 to eight degrees C rather than of-20 degrees C that was needed for the previous one. World Health Organisation pre-qualification is awaited by the corporate for the new variant, which will make it accessible to almost 100 countries.

A syringe loaded with single-dose also will be available to the remotest small private clinics and it cost somewhere between $1 and $1.5, which is 2.5% above the previous edition, reveals company officials.

Rotavirus vaccine is an oral drop to stop diarrhoeal deaths in children. Three doses of 5 drops each need to tend to children at 6 weeks, 10 weeks and 14 weeks to guard against rotavirus infection. this is often crucial as Diarrhoea tops the chart of causes for child death under five years aged.

The company claims it's already sold 100 million doses of Rotavac in around 25 countries.

Tags : #bharatbiotech #newrotavirusvaccine #medicircle

Related Stories

13 Sep

Indegene Acquires DT Associates, Provides End-to-end Enterprise Solution for Customer Excellence - From Consulting to Operations

Indegene, a leading next-generation solutions organization for the Life Sciences industry globally, has entered into an agreement to acquire a majority stake in London-based DT Associates, a consulting company exclusively focused on helping pharmaceutical companies achieve excellence in Customer Experience (CX) and Digital Operations (DX). DT Associates will operate as a separate entity in Indegene Private Ltd, as 'DT Consulting' effective immediately.

View

-Advertisements-




Trending Now

1.5 Million Bottles Recalled: Is Your ADHD Medication Safe?March 03, 2025
Dressed for Trust: Why Doctors Must Wear White Aprons AgainMarch 03, 2025
India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?March 01, 2025
Pregnant and Pained: Is Paracetamol Poisoning Our Unborn Children?March 01, 2025
Are Your Idlis Poisoning You? The Hidden Dangers of Plastic in Indian KitchensMarch 01, 2025
Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma DreamFebruary 27, 2025
A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage SurgeryFebruary 27, 2025
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItFebruary 27, 2025
Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks SoFebruary 26, 2025
The Inequality of Survival: Why Some Women Die While Others LiveFebruary 26, 2025
The Corporate Invasion of Indian Hospitals: What It Means for YouFebruary 26, 2025
5 Simple Daily Habits to Keep Your Joints Healthy and Pain-FreeFebruary 25, 2025
Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in IndiaFebruary 25, 2025
With only 70 months left to end AIDS why is the urgency missing?February 25, 2025
Drenched in Oil: Is India Cooking Its Way to an Obesity Epidemic?February 25, 2025
Transforming Education: How Online Learning Platforms are Reshaping Study Material for Board and Competitive ExamsFebruary 24, 2025
February 24, 2025
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaFebruary 24, 2025
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemFebruary 24, 2025
From Science Fiction to Reality: AI Now Detects Blindness Before It StartsFebruary 24, 2025